The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells

Lung cancer

1 Posts

1 Users

0 Likes

1,152 Views

RSS

johan

(@j)

Joined: 5 years ago

Posts: 2115

Topic starter 13/06/2020 2:21 am

"Current results suggest a potential role of NaPB as a sensitizing agent in NSCLC."

Quote

Topic Tags

NaPB phenylbutyrate

Forum Icons: Forum contains no unread posts Forum contains unread posts

Topic Icons: Not Replied Replied Active Hot Sticky Unapproved Solved Private Closed